Skip to main content
TEYI PHARMACEUTICAL GROUP CO.,LTD logo

TEYI PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002728 ISIN · CNE100001WK6 LEI · 300300ZUIZCFPGQWOZ61 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,597 across all filing types
Latest filing 2015-11-11 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002728

About TEYI PHARMACEUTICAL GROUP CO.,LTD

https://www.tczy.com.cn

TEYI PHARMACEUTICAL GROUP CO.,LTD. specializes in the research, development, manufacturing, and distribution of pharmaceutical products. The company's portfolio primarily consists of Chinese patent medicines and chemical drug preparations. Its flagship product, Zhike Bao Tablets, is widely recognized for treating chronic bronchitis and cough-related ailments. Beyond respiratory health, the group produces a diverse range of medications covering cardiovascular diseases, gastrointestinal disorders, and anti-infective treatments. Teyi Pharmaceutical operates modern production facilities and maintains a robust distribution network to serve healthcare providers and pharmacies. The company emphasizes the integration of traditional medicinal knowledge with modern pharmaceutical technology to enhance product efficacy and safety.

Recent filings

Filing Released Lang Actions
独立董事候选人声明（杨小龙）
Board/Management Information Classification · 100% confidence The document is a public declaration by an independent director candidate of Guangdong Taicheng Pharmaceutical Co., Ltd. It contains detailed statements about the candidate's qualifications, independence, compliance with laws and regulations, and other eligibility criteria for serving as an independent director. There are no financial statements, no discussion of company performance, no voting results, no meeting materials, and no mention of any report publication or regulatory filing. The content is focused on board/management information specifically related to the nomination and qualifications of a board member candidate. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report but a standalone declaration by a board candidate.
2015-11-11 Chinese
公司章程（2015年11月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Guangdong Taicheng Pharmaceutical Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, shareholder meetings, share issuance, share transfer, and other governance matters. It is a legal and governance document that sets out the internal rules and regulations of the company. There is no indication that this is an annual report, financial report, or any announcement related to voting results or capital changes. The content aligns with governance information about the company's internal rules and board structure. Therefore, the document fits the category of Governance Information (CGR).
2015-11-11 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 100% confidence The document is a formal statement from the board nominating an independent director candidate for the company's board. It includes detailed qualifications, compliance with regulatory requirements, and declarations about the nominee's independence and eligibility. There is no financial data, earnings information, or report publication mentioned. The content is focused on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and does not indicate an announcement of a report or certification, so it is not RPA or RNS.
2015-11-11 Chinese
独立董事候选人声明（卢北京）
Regulatory Filings Classification · 95% confidence The document is a formal declaration by an independent director candidate of Guangdong Taicheng Pharmaceutical Co., Ltd. It contains detailed statements about the candidate's qualifications, compliance with laws and regulations, and independence criteria. There is no financial data, no report of financial performance, no voting results, no management changes, and no mention of any meeting or report publication. The document is a regulatory compliance statement related to director candidacy, which does not fit into categories like Annual Report, Management Information, or Proxy Solicitation. It is a regulatory filing type document that serves as a formal declaration for regulatory and stock exchange compliance purposes.
2015-11-11 Chinese
独立董事关于公司董事会换届发表的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the re-election of the company's board of directors and supervisory board. It references compliance with relevant laws and regulations, nomination and voting procedures, and qualifications of candidates. There is no financial data, no mention of a report being attached or published, and the content focuses on board/management changes. This fits the category of Board/Management Information (MANG). The document length is short and specific to board nominations, not a full report or announcement of voting results.
2015-11-11 Chinese
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of Guangdong Taicheng Pharmaceutical Co., Ltd. nominating an independent director candidate, Yang Xiaolong. It details the candidate's qualifications, compliance with legal and regulatory requirements, and independence criteria. There is no financial data, no report or results, and no mention of meetings or voting results. This is a formal announcement related to board/management information, specifically about a board nomination. Therefore, the document fits best under Board/Management Information (MANG). The document length is short and focused on nomination, not a full report or announcement of voting results.
2015-11-11 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.